Läkemedel på rekvisition 2026 SLL450 del 2
- Published
- 19 May 2026
- Estimated value
- 450,000,000 kr
- Place of performance
- SE110
- Procedure
- open
- Lots
- 1
- Notice number
- 00340996-2026
- Reference
- 632e092b-5f61-4660-9cf2-450c0d621400
- Official source
- Official source
CPV codes
- 33600000Productos farmacéuticos
Description
Rekvisitionsläkemedel inom olika ATC-koder.
Awards
| Awarded to | Amount | Date |
|---|---|---|
| Accord Healthcare AB | — | — |
| Amgen AB | — | — |
| Bayer AB | — | — |
| Celltrion Sweden AB | — | — |
| Fresenius Kabi AB | — | — |
| FrostPharma AB | — | — |
| Gedeon Richter Nordics AB | — | — |
| Macure Pharma | — | — |
| Medac Gesellschaft für klinische Spezialpräparate mbH | — | — |
| Medical Valley Invest AB | — | — |
Frequently asked questions
- What is the estimated value of this tender?
- The estimated value published by the buyer is 450,000,000 kr.
- Who is the buyer of this tender?
- The contracting authority is Karolinska Universitetssjukhuset (European Union).
Get alerts for tenders like this
Create a free account and receive new tenders from European Union matching your business, every day.
Create a free account and receive new tenders from European Union matching your business, every day.